Table of Content

1 Prostate Cancer Drugs Market Overview
1.1 Prostate Cancer Drugs Product Overview
1.2 Prostate Cancer Drugs Market Segment by Type
1.2.1 Hormonal Therapy
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.3 Global Prostate Cancer Drugs Market Size by Type
1.3.1 Global Prostate Cancer Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Prostate Cancer Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Prostate Cancer Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Prostate Cancer Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Prostate Cancer Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Prostate Cancer Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Prostate Cancer Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Prostate Cancer Drugs Sales Breakdown by Type (2018-2024)
2 Global Prostate Cancer Drugs Market Competition by Company
2.1 Global Top Players by Prostate Cancer Drugs Sales (2018-2024)
2.2 Global Top Players by Prostate Cancer Drugs Revenue (2018-2024)
2.3 Global Top Players by Prostate Cancer Drugs Price (2018-2024)
2.4 Global Top Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Prostate Cancer Drugs Market Competitive Situation and Trends
2.5.1 Prostate Cancer Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Prostate Cancer Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Cancer Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Prostate Cancer Drugs Market
2.8 Key Manufacturers Prostate Cancer Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Prostate Cancer Drugs Status and Outlook by Region
3.1 Global Prostate Cancer Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Prostate Cancer Drugs Historic Market Size by Region
3.2.1 Global Prostate Cancer Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Prostate Cancer Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Prostate Cancer Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Prostate Cancer Drugs Forecasted Market Size by Region
3.3.1 Global Prostate Cancer Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Prostate Cancer Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Prostate Cancer Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Prostate Cancer Drugs by Application
4.1 Prostate Cancer Drugs Market Segment by Application
4.1.1 Clinics
4.1.2 Hospitals
4.1.3 Others
4.2 Global Prostate Cancer Drugs Market Size by Application
4.2.1 Global Prostate Cancer Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Prostate Cancer Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Prostate Cancer Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Prostate Cancer Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Prostate Cancer Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Prostate Cancer Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Prostate Cancer Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Prostate Cancer Drugs Sales Breakdown by Application (2018-2024)
5 North America Prostate Cancer Drugs by Country
5.1 North America Prostate Cancer Drugs Historic Market Size by Country
5.1.1 North America Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Prostate Cancer Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Prostate Cancer Drugs Sales in Value by Country (2018-2024)
5.2 North America Prostate Cancer Drugs Forecasted Market Size by Country
5.2.1 North America Prostate Cancer Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Prostate Cancer Drugs Sales in Value by Country (2024-2034)
6 Europe Prostate Cancer Drugs by Country
6.1 Europe Prostate Cancer Drugs Historic Market Size by Country
6.1.1 Europe Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Prostate Cancer Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Prostate Cancer Drugs Sales in Value by Country (2018-2024)
6.2 Europe Prostate Cancer Drugs Forecasted Market Size by Country
6.2.1 Europe Prostate Cancer Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Prostate Cancer Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Prostate Cancer Drugs by Region
7.1 Asia-Pacific Prostate Cancer Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Prostate Cancer Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Prostate Cancer Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Prostate Cancer Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Prostate Cancer Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Prostate Cancer Drugs Sales in Value by Region (2024-2034)
8 Latin America Prostate Cancer Drugs by Country
8.1 Latin America Prostate Cancer Drugs Historic Market Size by Country
8.1.1 Latin America Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Prostate Cancer Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Prostate Cancer Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Prostate Cancer Drugs Forecasted Market Size by Country
8.2.1 Latin America Prostate Cancer Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Prostate Cancer Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Prostate Cancer Drugs by Country
9.1 Middle East and Africa Prostate Cancer Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Prostate Cancer Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Prostate Cancer Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Prostate Cancer Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Prostate Cancer Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Prostate Cancer Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AbbVie Prostate Cancer Drugs Products Offered
10.1.5 AbbVie Recent Development
10.2 Astellas Pharma
10.2.1 Astellas Pharma Company Information
10.2.2 Astellas Pharma Introduction and Business Overview
10.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Astellas Pharma Prostate Cancer Drugs Products Offered
10.2.5 Astellas Pharma Recent Development
10.3 Astra Zeneca
10.3.1 Astra Zeneca Company Information
10.3.2 Astra Zeneca Introduction and Business Overview
10.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Astra Zeneca Prostate Cancer Drugs Products Offered
10.3.5 Astra Zeneca Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Johnson & Johnson Prostate Cancer Drugs Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Sanofi Prostate Cancer Drugs Products Offered
10.5.5 Sanofi Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 GlaxoSmithKline Prostate Cancer Drugs Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Merck Group
10.7.1 Merck Group Company Information
10.7.2 Merck Group Introduction and Business Overview
10.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Merck Group Prostate Cancer Drugs Products Offered
10.7.5 Merck Group Recent Development
10.8 Novartis
10.8.1 Novartis Company Information
10.8.2 Novartis Introduction and Business Overview
10.8.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Novartis Prostate Cancer Drugs Products Offered
10.8.5 Novartis Recent Development
10.9 Amgen
10.9.1 Amgen Company Information
10.9.2 Amgen Introduction and Business Overview
10.9.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Amgen Prostate Cancer Drugs Products Offered
10.9.5 Amgen Recent Development
10.10 Bayer HealthCare
10.10.1 Bayer HealthCare Company Information
10.10.2 Bayer HealthCare Introduction and Business Overview
10.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Bayer HealthCare Prostate Cancer Drugs Products Offered
10.10.5 Bayer HealthCare Recent Development
10.11 Ferring Pharmaceutical
10.11.1 Ferring Pharmaceutical Company Information
10.11.2 Ferring Pharmaceutical Introduction and Business Overview
10.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Products Offered
10.11.5 Ferring Pharmaceutical Recent Development
10.12 Janssen Pharmaceuticals
10.12.1 Janssen Pharmaceuticals Company Information
10.12.2 Janssen Pharmaceuticals Introduction and Business Overview
10.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Products Offered
10.12.5 Janssen Pharmaceuticals Recent Development
10.13 Endo Pharmaceuticals
10.13.1 Endo Pharmaceuticals Company Information
10.13.2 Endo Pharmaceuticals Introduction and Business Overview
10.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Products Offered
10.13.5 Endo Pharmaceuticals Recent Development
10.14 BMS
10.14.1 BMS Company Information
10.14.2 BMS Introduction and Business Overview
10.14.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 BMS Prostate Cancer Drugs Products Offered
10.14.5 BMS Recent Development
10.15 Takeda Pharmaceuticals
10.15.1 Takeda Pharmaceuticals Company Information
10.15.2 Takeda Pharmaceuticals Introduction and Business Overview
10.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Products Offered
10.15.5 Takeda Pharmaceuticals Recent Development
10.16 Northwest Biotherapeutics
10.16.1 Northwest Biotherapeutics Company Information
10.16.2 Northwest Biotherapeutics Introduction and Business Overview
10.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Products Offered
10.16.5 Northwest Biotherapeutics Recent Development
10.17 Teva Pharmaceutical
10.17.1 Teva Pharmaceutical Company Information
10.17.2 Teva Pharmaceutical Introduction and Business Overview
10.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Teva Pharmaceutical Prostate Cancer Drugs Products Offered
10.17.5 Teva Pharmaceutical Recent Development
10.18 Boehringer Ingelheim
10.18.1 Boehringer Ingelheim Company Information
10.18.2 Boehringer Ingelheim Introduction and Business Overview
10.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Boehringer Ingelheim Prostate Cancer Drugs Products Offered
10.18.5 Boehringer Ingelheim Recent Development
10.19 Foresee Pharmaceuticals
10.19.1 Foresee Pharmaceuticals Company Information
10.19.2 Foresee Pharmaceuticals Introduction and Business Overview
10.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Products Offered
10.19.5 Foresee Pharmaceuticals Recent Development
10.20 Tokai Pharmaceuticals
10.20.1 Tokai Pharmaceuticals Company Information
10.20.2 Tokai Pharmaceuticals Introduction and Business Overview
10.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Products Offered
10.20.5 Tokai Pharmaceuticals Recent Development
10.21 Spectrum Pharmaceuticals
10.21.1 Spectrum Pharmaceuticals Company Information
10.21.2 Spectrum Pharmaceuticals Introduction and Business Overview
10.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Products Offered
10.21.5 Spectrum Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Prostate Cancer Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Prostate Cancer Drugs Industrial Chain Analysis
11.4 Prostate Cancer Drugs Market Dynamics
11.4.1 Prostate Cancer Drugs Industry Trends
11.4.2 Prostate Cancer Drugs Market Drivers
11.4.3 Prostate Cancer Drugs Market Challenges
11.4.4 Prostate Cancer Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Prostate Cancer Drugs Distributors
12.3 Prostate Cancer Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Hormonal Therapy
Table 2. Major Company of Chemotherapy
Table 3. Major Company of Immunotherapy
Table 4. Major Company of Targeted Therapy
Table 5. Global Prostate Cancer Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Prostate Cancer Drugs Sales by Type (2018-2024) & (K MT)
Table 7. Global Prostate Cancer Drugs Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Prostate Cancer Drugs Sales by Type (2018-2024) & (US& Million)
Table 9. Global Prostate Cancer Drugs Market Share in Value by Type (2018-2024)
Table 10. Global Prostate Cancer Drugs Price by Type (2018-2024) & (USD/MT)
Table 11. Global Prostate Cancer Drugs Sales by Type (2024-2034) & (K MT)
Table 12. Global Prostate Cancer Drugs Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Prostate Cancer Drugs Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Prostate Cancer Drugs Sales Market Share in Value by Type (2024-2034)
Table 15. Global Prostate Cancer Drugs Price by Type (2024-2034) & (USD/MT)
Table 16. North America Prostate Cancer Drugs Sales by Type (2018-2024) & (K MT)
Table 17. North America Prostate Cancer Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Prostate Cancer Drugs Sales (K MT) by Type (2018-2024)
Table 19. Europe Prostate Cancer Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Prostate Cancer Drugs Sales (K MT) by Type (2018-2024)
Table 21. Asia-Pacific Prostate Cancer Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Prostate Cancer Drugs Sales (K MT) by Type (2018-2024)
Table 23. Latin America Prostate Cancer Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Prostate Cancer Drugs Sales (K MT) by Type (2018-2024)
Table 25. Middle East and Africa Prostate Cancer Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Prostate Cancer Drugs Sales by Company (2018-2024) & (K MT)
Table 27. Global Prostate Cancer Drugs Sales Share by Company (2018-2024)
Table 28. Global Prostate Cancer Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Prostate Cancer Drugs Revenue Share by Company (2018-2024)
Table 30. Global Market Prostate Cancer Drugs Price by Company (2018-2024) & (USD/MT)
Table 31. Global Prostate Cancer Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Prostate Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Cancer Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into Prostate Cancer Drugs Market
Table 35. Key Manufacturers Prostate Cancer Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Prostate Cancer Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Prostate Cancer Drugs Sales by Region (2018-2024) & (K MT)
Table 39. Global Prostate Cancer Drugs Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Prostate Cancer Drugs Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Prostate Cancer Drugs Sales Market Share in Value by Region (2018-2024)
Table 42. Global Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 43. Global Prostate Cancer Drugs Sales by Region (2024-2034) & (K MT)
Table 44. Global Prostate Cancer Drugs Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Prostate Cancer Drugs Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Prostate Cancer Drugs Sales Market Share in Value by Region (2024-2034)
Table 47. Global Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 48. Global Prostate Cancer Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Prostate Cancer Drugs Sales by Application (2018-2024) & (K MT)
Table 50. Global Prostate Cancer Drugs Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Prostate Cancer Drugs Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Prostate Cancer Drugs Sales Market Share in Value by Application (2018-2024)
Table 53. Global Prostate Cancer Drugs Price by Application (2018-2024) & (USD/MT)
Table 54. Global Prostate Cancer Drugs Sales by Application (2024-2034) & (K MT)
Table 55. Global Prostate Cancer Drugs Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Prostate Cancer Drugs Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Prostate Cancer Drugs Sales Market Share in Value by Application (2024-2034)
Table 58. Global Prostate Cancer Drugs Price by Application (2024-2034) & (USD/MT)
Table 59. North America Prostate Cancer Drugs Sales by Application (2018-2024) (K MT)
Table 60. North America Prostate Cancer Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Prostate Cancer Drugs Sales by Application (2018-2024) (K MT)
Table 62. Europe Prostate Cancer Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Prostate Cancer Drugs Sales by Application (2018-2024) (K MT)
Table 64. Asia-Pacific Prostate Cancer Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Prostate Cancer Drugs Sales by Application (2018-2024) (K MT)
Table 66. Latin America Prostate Cancer Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Prostate Cancer Drugs Sales by Application (2018-2024) (K MT)
Table 68. Middle East and Africa Prostate Cancer Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Prostate Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 70. North America Prostate Cancer Drugs Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Prostate Cancer Drugs Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Prostate Cancer Drugs Sales Market Share in Value by Country (2018-2024)
Table 73. North America Prostate Cancer Drugs Sales by Country (2024-2034) & (K MT)
Table 74. North America Prostate Cancer Drugs Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Prostate Cancer Drugs Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Prostate Cancer Drugs Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Prostate Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 78. Europe Prostate Cancer Drugs Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Prostate Cancer Drugs Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Prostate Cancer Drugs Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Prostate Cancer Drugs Sales by Country (2024-2034) & (K MT)
Table 82. Europe Prostate Cancer Drugs Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Prostate Cancer Drugs Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Prostate Cancer Drugs Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Prostate Cancer Drugs Sales by Region (2018-2024) & (K MT)
Table 86. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Prostate Cancer Drugs Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Prostate Cancer Drugs Sales by Region (2024-2034) & (K MT)
Table 90. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Prostate Cancer Drugs Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Prostate Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 94. Latin America Prostate Cancer Drugs Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Prostate Cancer Drugs Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Prostate Cancer Drugs Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Prostate Cancer Drugs Sales by Country (2024-2034) & (K MT)
Table 98. Latin America Prostate Cancer Drugs Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Prostate Cancer Drugs Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Prostate Cancer Drugs Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Prostate Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 102. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Prostate Cancer Drugs Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Prostate Cancer Drugs Sales by Country (2024-2034) & (K MT)
Table 106. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Prostate Cancer Drugs Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Value by Country (2024-2034)
Table 109. AbbVie Company Information
Table 110. AbbVie Introduction and Business Overview
Table 111. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 112. AbbVie Prostate Cancer Drugs Product
Table 113. AbbVie Recent Development
Table 114. Astellas Pharma Company Information
Table 115. Astellas Pharma Introduction and Business Overview
Table 116. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 117. Astellas Pharma Prostate Cancer Drugs Product
Table 118. Astellas Pharma Recent Development
Table 119. Astra Zeneca Company Information
Table 120. Astra Zeneca Introduction and Business Overview
Table 121. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 122. Astra Zeneca Prostate Cancer Drugs Product
Table 123. Astra Zeneca Recent Development
Table 124. Johnson & Johnson Company Information
Table 125. Johnson & Johnson Introduction and Business Overview
Table 126. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 127. Johnson & Johnson Prostate Cancer Drugs Product
Table 128. Johnson & Johnson Recent Development
Table 129. Sanofi Company Information
Table 130. Sanofi Introduction and Business Overview
Table 131. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 132. Sanofi Prostate Cancer Drugs Product
Table 133. Sanofi Recent Development
Table 134. GlaxoSmithKline Company Information
Table 135. GlaxoSmithKline Introduction and Business Overview
Table 136. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 137. GlaxoSmithKline Prostate Cancer Drugs Product
Table 138. GlaxoSmithKline Recent Development
Table 139. Merck Group Company Information
Table 140. Merck Group Introduction and Business Overview
Table 141. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 142. Merck Group Prostate Cancer Drugs Product
Table 143. Merck Group Recent Development
Table 144. Novartis Company Information
Table 145. Novartis Introduction and Business Overview
Table 146. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 147. Novartis Prostate Cancer Drugs Product
Table 148. Novartis Recent Development
Table 149. Amgen Company Information
Table 150. Amgen Introduction and Business Overview
Table 151. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 152. Amgen Prostate Cancer Drugs Product
Table 153. Amgen Recent Development
Table 154. Bayer HealthCare Company Information
Table 155. Bayer HealthCare Introduction and Business Overview
Table 156. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 157. Bayer HealthCare Prostate Cancer Drugs Product
Table 158. Bayer HealthCare Recent Development
Table 159. Ferring Pharmaceutical Company Information
Table 160. Ferring Pharmaceutical Introduction and Business Overview
Table 161. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 162. Ferring Pharmaceutical Prostate Cancer Drugs Product
Table 163. Ferring Pharmaceutical Recent Development
Table 164. Janssen Pharmaceuticals Company Information
Table 165. Janssen Pharmaceuticals Introduction and Business Overview
Table 166. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 167. Janssen Pharmaceuticals Prostate Cancer Drugs Product
Table 168. Janssen Pharmaceuticals Recent Development
Table 169. Endo Pharmaceuticals Company Information
Table 170. Endo Pharmaceuticals Introduction and Business Overview
Table 171. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 172. Endo Pharmaceuticals Prostate Cancer Drugs Product
Table 173. Endo Pharmaceuticals Recent Development
Table 174. BMS Company Information
Table 175. BMS Introduction and Business Overview
Table 176. BMS Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 177. BMS Prostate Cancer Drugs Product
Table 178. BMS Recent Development
Table 179. Takeda Pharmaceuticals Company Information
Table 180. Takeda Pharmaceuticals Introduction and Business Overview
Table 181. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 182. Takeda Pharmaceuticals Prostate Cancer Drugs Product
Table 183. Takeda Pharmaceuticals Recent Development
Table 184. Northwest Biotherapeutics Company Information
Table 185. Northwest Biotherapeutics Introduction and Business Overview
Table 186. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 187. Northwest Biotherapeutics Prostate Cancer Drugs Product
Table 188. Northwest Biotherapeutics Recent Development
Table 189. Teva Pharmaceutical Company Information
Table 190. Teva Pharmaceutical Introduction and Business Overview
Table 191. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 192. Teva Pharmaceutical Prostate Cancer Drugs Product
Table 193. Teva Pharmaceutical Recent Development
Table 194. Boehringer Ingelheim Company Information
Table 195. Boehringer Ingelheim Introduction and Business Overview
Table 196. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 197. Boehringer Ingelheim Prostate Cancer Drugs Product
Table 198. Boehringer Ingelheim Recent Development
Table 199. Foresee Pharmaceuticals Company Information
Table 200. Foresee Pharmaceuticals Introduction and Business Overview
Table 201. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 202. Foresee Pharmaceuticals Prostate Cancer Drugs Product
Table 203. Foresee Pharmaceuticals Recent Development
Table 204. Tokai Pharmaceuticals Company Information
Table 205. Tokai Pharmaceuticals Introduction and Business Overview
Table 206. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 207. Tokai Pharmaceuticals Prostate Cancer Drugs Product
Table 208. Tokai Pharmaceuticals Recent Development
Table 209. Spectrum Pharmaceuticals Company Information
Table 210. Spectrum Pharmaceuticals Introduction and Business Overview
Table 211. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 212. Spectrum Pharmaceuticals Prostate Cancer Drugs Product
Table 213. Spectrum Pharmaceuticals Recent Development
Table 214. Key Raw Materials Lists
Table 215. Raw Materials Key Suppliers Lists
Table 216. Prostate Cancer Drugs Market Trends
Table 217. Prostate Cancer Drugs Market Drivers
Table 218. Prostate Cancer Drugs Market Challenges
Table 219. Prostate Cancer Drugs Market Restraints
Table 220. Prostate Cancer Drugs Distributors List
Table 221. Prostate Cancer Drugs Downstream Customers
Table 222. Research Programs/Design for This Report
Table 223. Key Data Information from Secondary Sources
Table 224. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Drugs Product Picture
Figure 2. Global Prostate Cancer Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Prostate Cancer Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Prostate Cancer Drugs Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Hormonal Therapy
Figure 6. Global Hormonal Therapy Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Chemotherapy
Figure 8. Global Chemotherapy Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Product Picture of Immunotherapy
Figure 10. Global Immunotherapy Sales YoY Growth (2018-2034) & (K MT)
Figure 11. Product Picture of Targeted Therapy
Figure 12. Global Targeted Therapy Sales YoY Growth (2018-2034) & (K MT)
Figure 13. Global Prostate Cancer Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Prostate Cancer Drugs Sales Market Share by Type in 2022 & 2034
Figure 15. North America Prostate Cancer Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America Prostate Cancer Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe Prostate Cancer Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe Prostate Cancer Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America Prostate Cancer Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Prostate Cancer Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostate Cancer Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostate Cancer Drugs Revenue in 2022
Figure 27. Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Clinics
Figure 29. Global Clinics Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Product Picture of Hospitals
Figure 31. Global Hospitals Sales YoY Growth (2018-2034) & (K MT)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K MT)
Figure 34. Global Prostate Cancer Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Prostate Cancer Drugs Sales Market Share by Application in 2022 & 2034
Figure 36. North America Prostate Cancer Drugs Sales Market Share in Volume by Application in 2022
Figure 37. North America Prostate Cancer Drugs Sales Market Share in Value by Application in 2022
Figure 38. Europe Prostate Cancer Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Europe Prostate Cancer Drugs Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Value by Application in 2022
Figure 42. Latin America Prostate Cancer Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Prostate Cancer Drugs Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Prostate Cancer Drugs Manufacturing Cost Structure
Figure 47. Prostate Cancer Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed